Citi raised the firm’s price target on RXO Inc. (RXO) to $18 from $15 and keeps a Neutral rating on the shares after meeting with management. The company acknowledged its recent results have been below expectations given macro pressures, including industrial weakness, but sounded upbeat on progress with its Coyote integration and significant earnings and free cash flow potential over the medium- to long-term, the analyst tells investors in a research note. The firm says RXO is balancing its long-term potential against near-term headwinds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target raised to $18 from $15 at BofA
- RXO, Inc. Balances Growth and Challenges in Earnings Call
- RXO Inc. price target lowered to $14 from $24 at UBS
- RXO, Inc. Hold Rating: Balancing Progress with Market Challenges and Freight Recession Concerns
- RXO, Inc. Reports Strong Revenue Growth Amid Integration Success